IDEXX Laboratories Inc IDXX

NASDAQ US Health Care

$533.44 ▲ +0.83% (+$4.38)

Index member: S&P 500

⬆️ Above Yest. High

Open $530.10

Prev Close $529.06

Day Range $522.11 – $536.84

52W Range $500.61 – $769.98

Market Cap $40.91B

P/E (TTM) 36.57

Beta 1.57

EPS (TTM) $14.23

📋 Company Profile

Industry	Health Care
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	1991-06-21
Shares Out.	78,880,000
Website	idexx.com/ ↗
Phone	12075560300
Employees	11,000
Revenue	$1.22B
Gross Profit	$779.1M
Net Income	$338.4M
Free Cash Flow	$1.25B
Total Assets	$3.44B
Total Liabilities	$1.83B
Equity	$1.61B

About IDEXX Laboratories Inc

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.

IDEXX Laboratories Inc is a publicly traded company under the ticker symbol IDXX on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.